Prednisone

Deltacortene, Lodotra e altri

Bibliografia - Quali fonti bibliografiche per Prednisone?

1. Alten R. et al., J. Rheumatol., 2010, 37 (10), 2025.


2. Aubry-Rozier B. et al., Rev. Med. Suisse, 2010, 6 (235), 307.


3. Baulieu E.E., Ann. N. Y. Acad. Sci., 1997, 828, 47.


4. Beenakker E.A.C. et al., Arch. Neurol., 2005, 62, 128.


5. Bell E.C. et al., Ann. Pharmacother., 2007, 41 (11), 1819.


6. Bruckner H.W. et al., Cancer Res., 1975, 35 (3), 801.


7. Buttgereit F. et al., Lancet, 2008, 371 (9608), 205.


8. Buttgereit F. et al., American College of Rheumatology, 2009, Philadelphia, US.


9. Buttgereit F. et al., Ann. Rheum. Dis., 2010, 69 (7), 1275.


10. Camara E.J. et al., Cardiol. Young., 2002, 12(2), 119.


11. Cisneros J.R., Murray K.M., Ann. Pharmacother., 1996, 30 (11), 1298.


12. Clarcks S. et al., J. Rheumatol., 1985, 12, 980.


13. Cutolo M. et al., Ann. Rheum. Dis., 2003, 62, 593.


14. Cutolo M, Straub R.H., Autoimmun. Rev., 2008, 7, 223.


15. Czaja A.J., Expert Rev. Gastroenterol. Hepatol., 2009, 3(3), 269.


16. Elezovic I., Srp. Arh. Celok. Lek., 2010, 138 Suppl 1, 64.


17. Feber J. et al., Pediatr. Nephrol., 2009, 24(5), 1027.


18. Food and Drug administration (FDA), Scheda Prodotto della specialità medicinale Rayos, 2012, 26 luglio.


19. Greenberg R.A. et al., Clin. Pediatr. (Phila)., 2008, 47(8), 817.


20. Houwerzijl E.J. et al., Ann. Hematol., 2008, 87(12), 975.


21. Informazioni sui farmaci, 2007, 31, 1.


22. Johnsen S.D. et al., J. Child Neurol., 2001, 16, 870.


23. Jonkman J.H., J. Allergy Clin. Immunol., 1986, 78 (4Pt 2), 736.


24. Kimura Y et al., J. Rheumatol., 2000, 27(8), 2018.


25. Kollef M.H., Schuster D.P., N. Engl. J. Med., 1995, 332, 27.


26. Koppe J.G. et al., Eur. J. Obst. Gyn. Repr. Biol., 1977, 7,293.


27. Kusunoki M. et al., Nippon Rinsho, 2007, 65 (10), 1781.


28.  Liu C. et al., J. Cardiovasc. Pharmacol., 2015, 66 (3): 316.


29. McKinzie B.P., Am. J. Med. Sci., 2010, 339(1), 1.


30. Mofid A. et al., Int. J. Clin. Pract., 2008, 62(3), 433.


31. Muscle Study Group, Neurology, 2008, 71 (6), 394.


32. Newnham D.M., Drug Saf., 2001, 24 (14), 1065.


33. Penzak S.R. et al., J. Acquir. Immune Defic. Syndr., 2005, 40 (5), 573.


34. Pincus T. et al., Ann. Rheum. Dis., 2009, 68 (11), 1715.


35. Qureschi F. et al., J. Pediatr., 2001, 139, 20.


36. Richette P., Bardin T., Lancet, 2010, 375 (9711), 318.


37. Sanchez-Negron F.A., Dermatol. Online J., 2004, 10 (3), 14.


38. Sarma G.R. et al., Antimicrob. Agents Chemother., 1980, 18 (5), 661.


39. Saulnier P.J. et al., Eur. J. Pediatr., 2010, 169 (6), 763.


40. Schulman E.A., Silberstein S.D., Neurology, 1992, 42 Suppl. 2, 16.


41. Shaffer L.G., Phillips M.D., Ann. Intern. Med., 1997, 127(3), 206.


42. Shakeri-Nejad K., Stahlmann R., Expert. Opin. Pharmacother., 2006, 7 (6), 639.


43. Shenfield G.M., Med. J. Aust., 1986, 144 (4), 205.


44. Shimoni Z. et al., Isr. Med. Assoc. J., 2007, 9(7), 537.


45. Sistek C.J., Ann. Pharmacother., 1992, 26(9), 1127.


46. Stone J.H. et al., J. Rheumatol., 1999, 26 (5), 1134.


47. Trombetti A. et al., Praxis (Bern 1994), 2004, 93 (11), 407.


48. Upton R.A., Clin. Pharmacokinet., 1991, 20 (1), 66.


49. Van der Hooft C.S. et al., Arch. Intern. Med., 2006, 166 (9), 1016.


50. Versaci F. et al., J. Am. Coll. Cardiol., 2002, 40, 1935.


51. Yap K.Y. et al., Clin. Ther., 2008, 30 (8), 1385.


52. Yucel S. et al., J. Urol., 2004, 172 (4 Pt 2), 1725.


53. Zhou F. et al., Clin Lymphoma Myeloma Leuk., 2010, 10 (1), 51.